82005-99-0
Chemical Structure
Trihexosylceramide (d18:1/24:0)
- CAS. Nr.: 82005-99-0
- Formula:C60H113NO18
- Molecular Weight:1136.55
IUPAC Name: N-((2S,3R,E)-1-(((2R,3R,4R,5S,6R)-5-(((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxyoctadec-4-en-2-yl)tetracosanamide
InChIKey: MRVRZXMLIKCXOT-SHLWWNIASA-N
SMILES: O([C@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@@H](CO)O[C@@H](OC[C@H](NC(CCCCCCCCCCCCCCCCCCCCCCC)=O)[C@@H](/C=C/CCCCCCCCCCCCC)O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O
Biological Activity: Trihexosylceramide (d18:1/24:0) is a globotriaosylceramide (Gb3) subtype with an unmodified d18:1 sphingosine moiety and a saturated C24:0 fatty acid chain, which serves as a biomarker for Fabry disease. Trihexosylceramide (d18:1/24:0) is applicable to the research of Fabry disease[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Trihexosylceramide (d18:1/24:0) | Trihexosylceramide (d18:1/24:0) is a globotriaosylceramide (Gb3) subtype with an unmodified d18:1 sphingosine moiety and a saturated C24:0 fatty acid chain, which serves as a biomarker for Fabry disease. Trihexosylceramide (d18:1/24:0) is applicable to the research of Fabry disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
